[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551569":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":41,"collaborators":20,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":20,"enrollmentInfo":53,"targetDuration":20,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":20,"overallStatus":29,"whyStopped":20,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Samsung Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Prostate cancer patient, candidate of definitive radiation treatment","EXPERIMENTAL","A single institution with a single group, a phase II study, we plan to evaluate grade 1 or higher rectal bleeding within 3 years in high-risk prostate cancer patients who received biodegradable substance injection followed by curative radiotherapy in combination with hormone therapy.",[13],"Radiation: Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"RADIATION","Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients","this researcher performed biodegradable material injection during radical radiotherapy in combination with hormone therapy in high - risk prostate cancer patients. after subdivision radical received radiation therapy We plan to conduct a phase II clinical study to evaluate the safety of prostate cancer patients.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Won Park, M.D., Ph.D.","CONTACT","+82-2-3410-2616","wonro.park@samsung.com",[28],{"facility":5,"status":29,"city":30,"state":20,"zip":31,"country":32,"countryCode":20,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Seoul","06351","South Korea",{"type":34,"coordinates":35},"Point",[36,37],126.9784,37.566,{"lat":37,"lon":36},[40],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":42,"investigatorFullName":43,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Won Park","100551569","phase-2-safety-of-dose-escalation-in-definitive-hypofractionated-radiation-therapy-and-hormone-therapy-with-spaceoar-tm-for-patients-with-high---risk-localized-prostate-cancer-desar-h-100551569",false,"NCT06461793","Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)","DESAR-H","Inclusion Criteria:\n\n1. Histopathologically confirmed prostate adenocarcinoma within 6 months of study enrollment\n2. Patients with prostate cancer at high risk or above (c T3a-T4 or grade group 4-5 or PSA \\> 20 n g\u002FmL) )\n3. Patients who have undergone or are scheduled to undergo hormone therapy for high-risk prostate cancer\n4. Adults over 20 years of age\n5. Whole body performance ECOG 0-1\n6. SpaceOAR Patients who consented to the procedure and study\n\nExclusion Criteria:\n\n1. prostate removal surgery, Patients with a history of lower pelvic surgery including rectal cancer surgery\n2. primary cancer Patients with posterior extracapsular extension\n3. Medically biodegradable substances such as bleeding predisposition Patients for whom infusion is not appropriate\n4. Patients with a history of previous pelvic radiation therapy\n5. Patients with lymph node metastasis or distant metastasis","MALE","20 Years",{"count":54,"type":55},33,"ESTIMATED","INTERVENTIONAL",[58],"PHASE2","Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients who underwent low-fractionation curative radiation therapy and hormone therapy",[61],"High Risk Prostate Carcinoma","2024-06-19",{"date":64,"type":65},"2024-06-21","ACTUAL",{"date":67,"type":65},"2023-09-12",{"date":69,"type":55},"2033-12-31",{"name":5,"class":6},1]